Trial Outcomes & Findings for Objective Vision Evaluation of Two Cosmetic Contact Lenses (NCT NCT04287036)
NCT ID: NCT04287036
Last Updated: 2025-04-27
Results Overview
Visual acuity on logMAR (Logarithm of Minimal Angle of Resolution) scale was evaluated at distance (4 meters) under high luminance high contrast, high luminance low contrast and low luminance high contrast with distance goggles using ETDRS (Early Treatment Diabetic Retinopathy Study) charts. Letter-by-letter results calculated the visual performance score for each chart read. logMAR scores closer to zero, or below zero, indicate a better visual acuity. A logMAR value of 0.0 is equivalent to 20/20 Snellen vision.
COMPLETED
NA
28 participants
20- Minutes Post-Lens Fitting
2025-04-27
Participant Flow
A total of 28 subjects were enrolled into this study. Of those enrolled 25 were dispensed study lenses and completed the study, while 3 subjects failed to meet all eligibility criteria.
Participant milestones
| Measure |
Test/Control
Subjects randomized to this sequence received the Test lens during the first period and then received the Control lens during the second period.
|
Control/Test
Subjects randomized to this sequence received the Control lens during the first period and then received the Test lens during the second period.
|
|---|---|---|
|
Period 1
STARTED
|
13
|
12
|
|
Period 1
COMPLETED
|
13
|
12
|
|
Period 1
NOT COMPLETED
|
0
|
0
|
|
Period 2
STARTED
|
13
|
12
|
|
Period 2
COMPLETED
|
13
|
12
|
|
Period 2
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Objective Vision Evaluation of Two Cosmetic Contact Lenses
Baseline characteristics by cohort
| Measure |
All Subjects
n=25 Participants
All subjects who were dispensed a study lens.
|
|---|---|
|
Age, Continuous
|
26.1 years
STANDARD_DEVIATION 4.39 • n=5 Participants
|
|
Sex: Female, Male
Female
|
24 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
7 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
3 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
15 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
25 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 20- Minutes Post-Lens FittingPopulation: All subjects who had successfully completed all visits and did not substantially deviate from the protocol.
Visual acuity on logMAR (Logarithm of Minimal Angle of Resolution) scale was evaluated at distance (4 meters) under high luminance high contrast, high luminance low contrast and low luminance high contrast with distance goggles using ETDRS (Early Treatment Diabetic Retinopathy Study) charts. Letter-by-letter results calculated the visual performance score for each chart read. logMAR scores closer to zero, or below zero, indicate a better visual acuity. A logMAR value of 0.0 is equivalent to 20/20 Snellen vision.
Outcome measures
| Measure |
Test
n=25 Participants
Subjects that wore the Test lens in either the first or second period of the study.
|
Control
n=25 Participants
Subjects that wore the Control lens in either the first or second period of the study.
|
|---|---|---|
|
Distance Binocular Visual Acuity (logMAR)
High Luminance High Contrast
|
-0.15 logMAR
Standard Deviation 0.074
|
-0.18 logMAR
Standard Deviation 0.069
|
|
Distance Binocular Visual Acuity (logMAR)
High Luminance Low Contrast
|
0.00 logMAR
Standard Deviation 0.083
|
-0.04 logMAR
Standard Deviation 0.070
|
|
Distance Binocular Visual Acuity (logMAR)
Low Luminance High Contrast with goggles
|
0.02 logMAR
Standard Deviation 0.094
|
0.01 logMAR
Standard Deviation 0.065
|
PRIMARY outcome
Timeframe: 20- Minutes Post-Lens FittingPopulation: All subjects who had successfully completed all visits and did not substantially deviate from the protocol.
Visual acuity on logMAR (Logarithm of Minimal Angle of Resolution) scale was evaluated at near (40 cm) under High luminance low contrast and low luminance high contrast with distance goggles using ETDRS (Early Treatment Diabetic Retinopathy Study) charts. Letter-by-letter results calculated the visual performance score for each chart read. logMAR scores closer to zero, or below zero, indicate a better visual acuity. A logMAR value of 0.0 is equivalent to 20/20 Snellen vision.
Outcome measures
| Measure |
Test
n=25 Participants
Subjects that wore the Test lens in either the first or second period of the study.
|
Control
n=25 Participants
Subjects that wore the Control lens in either the first or second period of the study.
|
|---|---|---|
|
Near BinocularVisual Acuity (logMAR)
High Luminance Low Contrast
|
0.04 logMAR
Standard Deviation 0.070
|
0.02 logMAR
Standard Deviation 0.076
|
|
Near BinocularVisual Acuity (logMAR)
Low Luminance High Contrast with goggles
|
-0.02 logMAR
Standard Deviation 0.072
|
-0.04 logMAR
Standard Deviation 0.064
|
PRIMARY outcome
Timeframe: 20- Minutes Post-Lens FittingPopulation: All subjects who had successfully completed all visits and did not substantially deviate from the protocol.
Quantitative Visual Acuity (qVA) was measured at distance (4 meter) under low room illumination (4 lux), low luminance, high contrast conditions in the right eye only and in both eyes using AST Sentio vision Testing System. During testing 25 triplets of test letters were displayed on a large stationary monitor (118 CM), the operator recorded the patient's responses using the remote (Android Tablet). After a testing session had been completed the software calculated the VA threshold. VA threshold was defined as the logMAR stimulus size at which the expected probability of correct letter identification is 66%. when both eyes are measured. The average median VA threshold was reported for each lens. Lower values indicate better vision.
Outcome measures
| Measure |
Test
n=50 eyes
Subjects that wore the Test lens in either the first or second period of the study.
|
Control
n=50 eyes
Subjects that wore the Control lens in either the first or second period of the study.
|
|---|---|---|
|
Quantitative Visual Acuity
Right Eye
|
0.061 logMAR
Standard Deviation 0.0889
|
0.051 logMAR
Standard Deviation 0.0749
|
|
Quantitative Visual Acuity
Both Eyes
|
-0.010 logMAR
Standard Deviation 0.0578
|
-0.039 logMAR
Standard Deviation 0.0645
|
PRIMARY outcome
Timeframe: 20- Minutes Post-Lens FittingPopulation: All subjects who had successfully completed all visits and did not substantially deviate from the protocol.
Area under the log Curve was measured at 1.5, 3, 6, 12 and 18 cycles per degree (cpd) in the right eye only and in both eyes using AST Sentio vision Testing System. During testing 25 triplets of test letters were displayed on a large stationary monitor (118 CM), the operator recorded the patient's responses using the remote (Android Tablet). After a testing session had been completed the software calculated the Area under the log contrast sensitivity function from 1.5 cpd to 18 cpd. The average area under the log curve was reported for each lens. Higher values indicate better vision. Number of eyes is 50 when both eyes are measured.
Outcome measures
| Measure |
Test
n=50 eyes
Subjects that wore the Test lens in either the first or second period of the study.
|
Control
n=50 eyes
Subjects that wore the Control lens in either the first or second period of the study.
|
|---|---|---|
|
Area Under Contrast Sensitivity Function Curve
Right Eye
|
1.254 log contrast sensitivity*cpd
Standard Deviation 0.1746
|
1.273 log contrast sensitivity*cpd
Standard Deviation 0.1584
|
|
Area Under Contrast Sensitivity Function Curve
Both Eyes
|
1.524 log contrast sensitivity*cpd
Standard Deviation 0.1092
|
1.535 log contrast sensitivity*cpd
Standard Deviation 0.1022
|
Adverse Events
Test
Control
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Meredith Bishop OD, MS, FAAO
Johnson & Johnson Vision Care
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: GT60